- Home
- QQQX vs CDNA Comparison
QQQX vs CDNA Comparison
Compare QQQX & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QQQX
- CDNA
- Stock Information
- Founded
- QQQX 2007
- CDNA 1998
- Country
- QQQX United States
- CDNA United States
- Employees
- QQQX N/A
- CDNA N/A
- Industry
- QQQX Finance Companies
- CDNA Medical Specialities
- Sector
- QQQX Finance
- CDNA Health Care
- Exchange
- QQQX Nasdaq
- CDNA Nasdaq
- Market Cap
- QQQX 1.2B
- CDNA 944.1M
- IPO Year
- QQQX N/A
- CDNA 2014
- Fundamental
- Price
- QQQX $25.76
- CDNA $22.58
- Analyst Decision
- QQQX
- CDNA Buy
- Analyst Count
- QQQX 0
- CDNA 8
- Target Price
- QQQX N/A
- CDNA $27.17
- AVG Volume (30 Days)
- QQQX 127.6K
- CDNA 816.5K
- Earning Date
- QQQX 01-01-0001
- CDNA 11-04-2024
- Dividend Yield
- QQQX 7.03%
- CDNA N/A
- EPS Growth
- QQQX N/A
- CDNA N/A
- EPS
- QQQX N/A
- CDNA N/A
- Revenue
- QQQX N/A
- CDNA $312,775,000.00
- Revenue This Year
- QQQX N/A
- CDNA $19.60
- Revenue Next Year
- QQQX N/A
- CDNA $10.26
- P/E Ratio
- QQQX N/A
- CDNA N/A
- Revenue Growth
- QQQX N/A
- CDNA 5.26
- 52 Week Low
- QQQX $20.27
- CDNA $7.42
- 52 Week High
- QQQX $25.99
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- QQQX 52.47
- CDNA 42.58
- Support Level
- QQQX $25.60
- CDNA $21.16
- Resistance Level
- QQQX $26.33
- CDNA $24.42
- Average True Range (ATR)
- QQQX 0.28
- CDNA 1.30
- MACD
- QQQX -0.04
- CDNA 0.16
- Stochastic Oscillator
- QQQX 59.86
- CDNA 43.83
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.